Cargando…

SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cells

CD47, expressed on a variety of tumor cells, confers immune resistance by delivering an inhibitory “don't eat me” signal to phagocytic cells via its myeloid-specific receptor SIRPα. Recent studies have shown that blocking the CD47-SIRPα axis with CD47-directed antibodies or antibody-derivatives...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponce, Laia Pascual, Fenn, Nadja C., Moritz, Nadine, Krupka, Christina, Kozik, Jan-Hendrik, Lauber, Kirsten, Subklewe, Marion, Hopfner, Karl-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355265/ https://www.ncbi.nlm.nih.gov/pubmed/28061465 http://dx.doi.org/10.18632/oncotarget.14500

Ejemplares similares

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
por: Tahk, Siret, et al.
Publicado: (2021)

SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells
por: Nuvolone, Mario, et al.
Publicado: (2013)

Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts
por: Theocharides, Alexandre P.A., et al.
Publicado: (2012)

Recent developments in immunotherapy of acute myeloid leukemia
por: Lichtenegger, Felix S., et al.
Publicado: (2017)

Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis
por: Shen, Qinjun, et al.
Publicado: (2022)

Phagocytic receptors activate and immune inhibitory receptor SIRPα inhibits phagocytosis through paxillin and cofilin
por: Gitik, Miri, et al.
Publicado: (2014)

THE TEMPERATURE COEFFICIENT OF PHAGOCYTOSIS
por: Fenn, Wallace O.
Publicado: (1922)

Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor–Mediated Phagocytosis
por: Oldenborg, Per-Arne, et al.
Publicado: (2001)

Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells
por: Schmitt, Saskia, et al.
Publicado: (2020)

Current status of immunotherapy in acute myeloid leukemia
por: Subklewe, Marion
Publicado: (2018)

THE PHAGOCYTOSIS OF SOLID PARTICLES : II. CARBON.
por: Fenn, Wallace O.
Publicado: (1921)

THE PHAGOCYTOSIS OF SOLID PARTICLES : I. QUARTZ.
por: Fenn, Wallace O.
Publicado: (1921)

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis()()
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2018)

SIRPαFc treatment targets human acute myeloid leukemia stem cells
por: Galkin, Oleksandr, et al.
Publicado: (2020)

Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013)

A modular and controllable T cell therapy platform for acute myeloid leukemia
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2021)

THE PHAGOCYTOSIS OF SOLID PARTICLES : III. CARBON AND QUARTZ.
por: Fenn, Wallace O.
Publicado: (1921)

The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer
por: Wang, Xiaojiao, et al.
Publicado: (2020)

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
por: Braciak, Todd A., et al.
Publicado: (2018)

EFFECT OF THE HYDROGEN ION CONCENTRATION ON THE PHAGOCYTOSIS AND ADHESIVENESS OF LEUCOCYTES
por: Fenn, Wallace O.
Publicado: (1922)

Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
por: Sakamoto, Mariko, et al.
Publicado: (2021)

Engagement of SIRPα Inhibits Growth and Induces Programmed Cell Death in Acute Myeloid Leukemia Cells
por: Irandoust, Mahban, et al.
Publicado: (2013)

Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint
por: Wu, Zhen-Hua, et al.
Publicado: (2022)

TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
por: Lin, Gloria H. Y., et al.
Publicado: (2017)

THE PHAGOCYTOSIS OF SOLID PARTICLES : IV. CARBON AND QUARTZ IN SOLUTIONS OF VARYING ACIDITY.
por: Fenn, Wallace O.
Publicado: (1923)

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab
por: Köhnke, Thomas, et al.
Publicado: (2015)

Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes
por: Gitik, Miri, et al.
Publicado: (2011)

OX130 Monoclonal Antibody Recognizes Human SIRPβ1 but Cross-Reacts on SIRPα from One Allele
por: Hatherley, Deborah, et al.
Publicado: (2016)

A SIRPα‐Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer
por: Huang, Yao, et al.
Publicado: (2020)

Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
por: Sim, Janet, et al.
Publicado: (2019)

Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
por: Kuo, Tracy C., et al.
Publicado: (2020)

Cancer Therapy Targeting CD47/SIRPα
por: Dizman, Nazli, et al.
Publicado: (2021)

Inflammatory Stimuli Reprogram Macrophage Phagocytosis to Macropinocytosis for the Rapid Elimination of Pathogens
por: BoseDasgupta, Somdeb, et al.
Publicado: (2014)

Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy
por: Khaldoyanidi, Sophia, et al.
Publicado: (2021)

T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
por: Daver, Naval, et al.
Publicado: (2021)

SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the “don’t eat me” signal and activating the “eat me” signal
por: Yu, Jifeng, et al.
Publicado: (2022)

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
por: Voets, Erik, et al.
Publicado: (2019)

An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging
por: Vick, Binje, et al.
Publicado: (2015)

Synapse Maturation by Activity-Dependent Ectodomain Shedding of SIRPα
por: Toth, Anna B., et al.
Publicado: (2013)

The SIRPα–CD47 immune checkpoint in NK cells
por: Deuse, Tobias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_78gisvd1e4mrrcuain9jta45mq